The Center for Molecular Imaging and Translational Technologies (CMITT), a National Center for Biomedical Imaging and Bioengineering, is proud to announce its relocation from Massachusetts General Hospital (MGH) to Yale University. CMITT investigators will continue their research endeavors in PET/MR imaging.
The decision to move CMITT to Yale University is all about creating new opportunities for collaboration, innovation, and growth in biomedical imaging. Yale’s strong academic community, cutting-edge facilities, and outstanding faculty make it the perfect place for CMITT to continue advancing research and making breakthroughs in the field.
CMITT's leadership team, including Director Dr. Georges El Fakhri and the TR&D leaders, will remain intact, ensuring continuity and dedication to the center's mission. Their expertise and vision will continue to guide CMITT's research efforts.
PET/MR imaging, a cutting-edge technique that combines positron emission tomography (PET) and magnetic resonance imaging (MRI), holds immense potential for revolutionizing disease diagnosis, treatment monitoring, and drug development. CMITT's multidisciplinary team of scientists, engineers, and clinicians is at the forefront of harnessing this technology to address critical healthcare challenges.